voriconazole has been researched along with Disseminated Fusariosis in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 59 (80.82) | 24.3611 |
2020's | 14 (19.18) | 2.80 |
Authors | Studies |
---|---|
Carlesse, F; Colombo, AL; Kontoyiannis, DP; Nobrega de Almeida, J; Rossato, L | 1 |
Fukumoto, T; Hamada, T; Sunagawa, K | 1 |
Haastrup, EK; Hare, RK; Helweg-Larsen, J; Overgaard, UM; Risum, M; Rubek, N | 1 |
Egger, M; Hoenigl, M; Jenks, JD; Nucci, M; Thompson, GR | 1 |
Aguilar-Zapata, D; Barragán-Reyes, A; Camacho, A; Cendejas, RF; Cornejo-Juárez, P; Guzmán, JMF; Hernández, MLG; Jácome, LEL; Juárez-Hernández, E; Nava-Ruiz, A; Ontañón-Zurita, D; Perales-Martínez, D; Reséndiz-Sánchez, J; Rincón-Zuno, J; Rivera-Martínez, NE | 1 |
Aquino, V; Borges, R; Meneghello Fuentefria, A; Ramirez-Castrillon, M; Rosa, PDD; Zubaran Goldani, L | 1 |
Fukuhara, N; Harigae, H; Ichikawa, S; Okitsu, Y; Onishi, Y; Onodera, K; Watanabe, S | 1 |
Cai, W; Li, J; Li, X; Lu, S; Ma, J; Shi, M; Xi, L; Zhang, J | 1 |
Chayakulkeeree, M; Chongtrakool, P; Yamasmith, E | 1 |
Auvity, S; Bouchand, C; Cisternino, S; Cohen, JF; Guery, R; Lanternier, F; Lortholary, O; Nguyen, D; Schlatter, J; Secretan, PH; Vidal, F | 1 |
de Andrade, SF; de Chaves, MA; Fernanda Andrzejewski Kaminski, T; Ferreira do Amaral, T; Flavio Souza de Oliveira, L; Fuentefria, AM; Monteiro da Silva Rodrigues Coutinho, N; Teixeira, ML | 1 |
Edwar, L; Janna, YM; Louisa, M; Rozaliyani, A | 1 |
Jiang, T; Sun, Y; Tan, J; Tang, J; Wu, Z; Yang, L | 1 |
Bourgeois, T; Lagrou, K; Lodewyck, T; Nulens, E; Reynders, M; Van Praet, J; Verbeke, V | 1 |
Alastruey-Izquierdo, A; Bonuomo, V; Buil, J; Campos-Herrero, MI; Candoni, A; Cattaneo, C; Colombo, AL; Delia, M; Dos Santos, MC; Farina, F; Forghieri, F; Fortun, J; Fracchiolla, N; Garcia-Vidal, C; Gudiol, C; Hoenigl, M; Jenks, J; Lass-Flörl, C; López-Soria, L; Nadali, G; Nucci, M; Pagano, L; Pérez Nadales, E; Rabagliati, R; Rico, JC; Roiz, MP; Sastre, E; Thompson, GR | 1 |
Acharya, NR; Das, M; Devi, L; Krishnan, T; Lietman, TM; McLeod, SD; O'Brien, KS; Oldenburg, CE; Patel, S; Prajna, NV; Rajaraman, R; Ray, KJ; Rose-Nussbaumer, J; Shah, R; Srinivasan, M; Zegans, ME | 1 |
Bonardel, G; Guernou, M; Lussato, D; Queneau, M; Seban, RD | 1 |
Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
Doki, N; Ikuta, S; Kurosawa, S; Ohashi, K; Sekiya, N; Takaki, Y | 1 |
Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG | 1 |
Acharya, NR; Amza, A; Lietman, TM; Loh, A; Mannis, MJ; Oldenburg, CE; Prajna, NV | 1 |
Hagiwara, S; Kiyota, N; Kunikata, H; Makimura, K; Maruyama, K; Nakazawa, T; Sato, N; Taniuchi, S; Toyokawa, M; Yoshida, M | 1 |
Brizendine, KD; Cober, E; Johnson, L; Nambiar, P | 1 |
Han, L; He, S; Li, X; Liu, X; Lui, Q; Ma, Q; Sun, S; Wang, L; Zhang, H; Zhang, J | 1 |
Albrieux, M; Borry, L; Garcia-Hermoso, D; Hoarau, G; Martin-Phipps, T; Peytral, J; Picot, S; Zitte-Zehler, K | 1 |
Al-Hatmi, AMS; Boral, H; de Hoog, GS; Erdem, E; Ilkit, M; Meis, JF; van Diepeningen, A; Yağmur, M | 1 |
Bilgihan, K; Erdoğan, M; Hizel, K; Kalkanci, A; Karakus, AK; Ozdemir, HB; Seker, T; Tum, AE; Unal, EA; Yesilirmak, N | 1 |
Capilla, J; Celis, A; Guarro, J; Guevara-Suarez, M; Navarro-Rodríguez, P; Paredes, K | 1 |
Díaz, MC; Luppi, M; Olivares, R | 1 |
England, MR; Schade, M | 1 |
Chen, Y; Fang, J; Yu, J; Zhang, K | 1 |
Arima, N; Iida, J; Inano, S; Kimura, M | 1 |
Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Sun, CQ | 1 |
Behera, A; Bhansali, A; Chakrabarti, A; De, D; Dutta, P; Premkumar, A; Rudramurthy, SM; Shah, VN | 1 |
Lai, J; McDonald, R; Pandya, V; Sutton, G | 1 |
Dony, A; Ducastelle, S; Ferry, T; Perpoint, T | 1 |
Anaissie, E; Araujo, V; Arikan-Akdagli, S; Atalla, A; Bertz, H; Cappellano, P; Carlesse, F; Cesaro, S; Cornely, OA; de Souza, CA; Galvão Castro, C; Hamerschlak, N; Härter, G; Heinz, WJ; Herbrecht, R; Hermansen, NE; Hoenigl, M; Josting, A; Kindo, A; Lortholary, O; Marr, KA; Mossad, SB; Nucci, M; Ogunc, D; Pagano, L; Pasqualotto, AC; Queiroz-Telles, F; Salles, MJ; Schaller, M; Sheppard, DC; Solza, C; Troke, PF; Vehreschild, MJ; Velasco, E | 1 |
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
Benatti, C; Cavallini, GM; Ducange, P; Volante, V | 1 |
Gamaletsou, MN; Walsh, TJ | 1 |
Bašková, L; Buchta, V; Feuermannová, A; Kubátová, A; Kutová, R; Váša, M; Vejsová, M | 1 |
Choi, KS; Han, SJ; Kim, ED; Rim, TH; Seo, KY; Yoon, SC | 1 |
Schnadig, VJ; Shah, SK; Terasaki, JM; Valentine, VG | 1 |
Azie, NE; Franks, B; Freifeld, AG; Horn, DL; Kauffman, CA; Schuster, MG | 1 |
Dannaoui, E; Datry, A; Fekkar, A; Imbert, S; Mazier, D; Meyer, I; Palous, M | 1 |
Bienvenu, AL; Boibieux, A; Cassier, P; Dananché, C; Gautheron, N; Nicolle, MC; Perraud, M; Sautour, M; Vanhems, P; Wegrzyn, J | 1 |
Bhanot, N; Garcia, RR; Min, Z; Narasimhan, S | 1 |
Akers, KS; Chung, KK; Graybill, JC; Mende, K; Murray, CK; Niece, KL; Rowan, MP | 1 |
Acharya, N; Lietman, TM; O'Brien, KS; Prajna, L; Prajna, NV; Rose-Nussbaumer, J; Sun, CQ | 1 |
Abd-Elaal, A; Abu-Elmagd, K; Bennett, A; El-Gazzaz, G; Fujiki, M; Hashimoto, K; Kandeel, A; Khanna, A; Parsi, M; Spinner, M | 1 |
Anaissie, E; Capone, D; Nouér, SA; Nucci, F; Nucci, M | 1 |
Al-Hatmi, AM; Bonifaz, A; Curfs-Breuker, I; De Hoog, GS; Meis, JF; Meletiadis, J | 1 |
Takenaka, M | 1 |
Arat, M; Çevik, E; Demirel, A; Efe İris, N; Güvenç, S; Koçulu, S; Özçelik, T | 1 |
Al-Hatmi, AM; Boekhout, T; Hamed, M; Lass-Flörl, C; Salah, H; Taj-Aldeen, SJ; Theelen, B; van Diepeningen, AD | 1 |
Costa, E; do Carmo, A; Marques, M; Quadrado, MJ; Tomé, R | 1 |
He, Y; Li, J; Li, JC; Sun, ST; Tao, SY; Wang, LL; Wang, LY; Xu, ZZ; Yu, XF; Zhang, JJ; Zhang, YQ; Zhu, L | 1 |
Akiti, T; Barreiros, G; Nouér, SA; Nucci, M; Trope, BM; Varon, AG | 1 |
Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M | 1 |
Agarwal, P; Sharma, N; Sinha, R; Titiyal, JS; Vajpayee, RB; Velpandian, T | 1 |
de Hoog, S; Debourgogne, A; Lozniewski, A; Machouart, M | 1 |
Chang, SE; Choi, JH; Kim, MS; Lee, HM; Lee, MW; Moon, KC; Sung, HS; Won, CH | 1 |
Bell, JE; Christenson, JC; Hulbert, ML; Imel, EA; Skiles, JL | 1 |
Bedini, A; Cavrini, F; Cocchi, S; Codeluppi, M; De Ruvo, N; Di Benedetto, F; Gennari, W; Gerunda, GE; Grottola, A; Guaraldi, G; Rumpianesi, F; Venturelli, C | 1 |
Gray, C; Labois, A; Lepretre, S | 1 |
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G | 1 |
Chandra, J; Ghannoum, MA; Mukherjee, PK; Pearlman, E; Sun, Y; Yu, C | 1 |
Ito, M; Kato, K; Kawashima, N; Matsumoto, K; Matsushita, N; Yoshida, N | 1 |
Behrens-Baumann, W; Haeberle, H; Hofmüller, W; Seibold, M; Tammer, I; Tintelnot, K; Walter, S; Wecke, T | 1 |
Bienvenu, AL; Borderie, V; Chaumeil, C; Cornet, M; Gaujoux, T; Goldschmidt, P; Grenouillet, F; Lortholary, O; Obenga, G; Pons, D; Ranque, S; Sitbon, K; Troke, P | 1 |
Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, PS; Lietman, TM; Mascarenhas, J; Oldenburg, CE; Porco, TC; Prajna, VN; Srinivasan, M; Sy, A; Vaitilingam, CM | 1 |
Barkai, G; Jacoby, E; Keller, N | 1 |
Ayed, S; Bouguila, H; Malek, I; Nacef, L | 1 |
13 review(s) available for voriconazole and Disseminated Fusariosis
Article | Year |
---|---|
How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
Topics: Adult; Antifungal Agents; Child; Fusariosis; Hematologic Neoplasms; Humans; Triazoles; Voriconazole | 2021 |
Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico.
Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System; Female; Fusariosis; Fusarium; Humans; Mexico; United States; Voriconazole | 2023 |
Isolated pulmonary fusariosis caused by Neocosmospora pseudensiformis in a liver transplant recipient: A case report and review of the literature.
Topics: Aged; Antifungal Agents; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Liver Transplantation; Lung Diseases, Fungal; Non-alcoholic Fatty Liver Disease; Radiography; Sputum; Treatment Outcome; Voriconazole | 2020 |
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: Case report and review of Fusarium infections in solid organ transplantation.
Topics: Abdomen; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Fatal Outcome; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Osteomyelitis; Tomography, X-Ray Computed; Transplants; Voriconazole | 2018 |
Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Female; Fusariosis; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Tigecycline; Voriconazole | 2019 |
Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.
Topics: Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug Therapy, Combination; Fusariosis; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2013 |
Fusarium falciforme infection of foot in a patient with type 2 diabetes mellitus: a case report and review of the literature.
Topics: Antifungal Agents; Biopsy, Fine-Needle; Diabetes Complications; Diabetes Mellitus, Type 2; Foot; Fusariosis; Fusarium; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Treatment of fungal disease in the setting of neutropenia.
Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Fusarium brain abscess: case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Seizures; Voriconazole | 2015 |
Fusariosis.
Topics: Amphotericin B; Antifungal Agents; Fusariosis; Fusarium; Humans; Immunocompromised Host; Pneumonia; Risk Factors; Transplant Recipients; Voriconazole | 2015 |
A Case of Cutaneous Fusariosis of the Scrotum as a Complication of Acute Myeloid Leukemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Scrotum; Skin; Voriconazole | 2016 |
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
3 trial(s) available for voriconazole and Disseminated Fusariosis
Article | Year |
---|---|
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Topics: Administration, Oral; Antifungal Agents; Cornea; Corneal Ulcer; Dose-Response Relationship, Drug; Double-Blind Method; Eye Infections, Fungal; Female; Follow-Up Studies; Fusariosis; Fusarium; Humans; Keratitis; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Visual Acuity; Voriconazole | 2017 |
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Topics: Antifungal Agents; Bayes Theorem; Corneal Ulcer; Expert Testimony; Eye Infections, Fungal; Fusariosis; Humans; Natamycin; Pyrimidines; Surveys and Questionnaires; Triazoles; Voriconazole | 2013 |
Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Double-Blind Method; Drug Resistance, Fungal; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Voriconazole | 2015 |
57 other study(ies) available for voriconazole and Disseminated Fusariosis
Article | Year |
---|---|
Invasive fusariosis presenting as multiple cutaneous nodules on the trunk and extremities.
Topics: Antifungal Agents; Extremities; Fusariosis; Fusarium; Humans; Skin Neoplasms; Voriconazole | 2022 |
Disseminated fusariosis with cerebral involvement in a patient with acute myeloid leukemia: Successful outcome with intrathecal -and systemic antifungal treatment.
Topics: Antifungal Agents; Female; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Neutropenia; Voriconazole | 2022 |
Fusariosis in Mexico: A 10-year retrospective series.
Topics: Amphotericin B; Antifungal Agents; Burns; Febrile Neutropenia; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Mexico; Retrospective Studies; Voriconazole | 2023 |
Epidemiological aspects and characterization of the resistance profile of
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Child; Child, Preschool; Female; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Voriconazole; Young Adult | 2019 |
Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis.
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cancer Survivors; Cord Blood Stem Cell Transplantation; Endophthalmitis; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Treatment Outcome; Vitrectomy; Voriconazole | 2020 |
Cutaneous fusariosis caused by Fusarium lichenicola in a child with hyper-immunoglobulin E syndrome.
Topics: Administration, Cutaneous; Administration, Oral; Amphotericin B; Antifungal Agents; Biopsy; Child, Preschool; DNA Mutational Analysis; Drug Therapy, Combination; Exome Sequencing; Face; Female; Fusariosis; Fusarium; Humans; Imidazoles; Injections, Intralesional; Job Syndrome; Skin; STAT3 Transcription Factor; Treatment Outcome; Voriconazole | 2020 |
Voriconazole topical cream formulation: evidence for stability and antifungal activity.
Topics: Administration, Topical; Adult; Antifungal Agents; Arm; Drug Interactions; Fusariosis; Fusarium; Humans; Male; Skin Cream; Voriconazole | 2020 |
Synergistic association of clioquinol with antifungal drugs against biofilm forms of clinical Fusarium isolates.
Topics: Antifungal Agents; Biofilms; Ciclopirox; Clioquinol; Drug Combinations; Drug Synergism; Fusariosis; Fusarium; Humans; Leukocytes; Microbial Sensitivity Tests; Voriconazole | 2020 |
Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Topics: Administration, Topical; Animals; Antifungal Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Rabbits; Voriconazole | 2020 |
The combined utilization of Chlorhexidine and Voriconazole or Natamycin to combat Fusarium infections.
Topics: Animals; Antifungal Agents; Chlorhexidine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fusariosis; Fusarium; Humans; Larva; Microbial Sensitivity Tests; Moths; Natamycin; Voriconazole | 2020 |
Successful Outcome of Disseminated Fusarium musae Fungemia with Skin Localization Treated with Liposomal Amphotericin B and Voriconazole in a Patient with Acute Myeloid Leukemia.
Topics: Amphotericin B; Antifungal Agents; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Voriconazole | 2020 |
Do high MICs predict the outcome in invasive fusariosis?
Topics: Antifungal Agents; Fusariosis; Humans; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole | 2021 |
The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated Fusariosis.
Topics: Amphotericin B; Antifungal Agents; Child; Female; Fluorodeoxyglucose F18; Fusariosis; Fusarium; Humans; Positron Emission Tomography Computed Tomography; Skin; Treatment Outcome; Voriconazole | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Sudden blindness as an initial manifestation of localized fusariosis in ethmoid sinus and optic nerve.
Topics: Aged; Blindness; Central Nervous System Fungal Infections; Diagnosis, Differential; Ethmoid Sinus; Fatal Outcome; Female; Fusariosis; Humans; Immunocompromised Host; Myelodysplastic Syndromes; Optic Nerve; Voriconazole | 2017 |
Evolution of Practice Patterns for the Treatment of Fungal Keratitis.
Topics: Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Fusariosis; Health Care Surveys; Humans; Natamycin; Practice Patterns, Physicians'; Surveys and Questionnaires; Voriconazole | 2017 |
Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Endophthalmitis; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Splenic Diseases; Treatment Outcome; Vitrectomy; Voriconazole | 2018 |
Identification and Characterization of Fusarium proliferatum, a New Species of Fungi that Cause Fungal Keratitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Ophthalmic Solutions; Peptide Elongation Factor 1; Sequence Analysis, DNA; Treatment Outcome; Voriconazole; Young Adult; Zea mays | 2018 |
[Fungal keratitis: A 5-year monocentric retrospective study on Reunion Island].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Corneal Injuries; Eye Infections, Fungal; Female; Fusariosis; Hospitals, University; Humans; Keratitis; Male; Middle Aged; Retrospective Studies; Reunion; Voriconazole; Wound Infection | 2018 |
Mycotic Keratitis Caused by Fusarium solani sensu stricto (FSSC5): A Case Series.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Female; Fungal Proteins; Fusariosis; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Netherlands; Peptide Elongation Factor 1; Sequence Analysis, DNA; Treatment Outcome; Turkey; Voriconazole | 2018 |
Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Collagen; Cornea; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Fungal; Fusariosis; Fusarium; Iontophoresis; Keratitis; Photochemotherapy; Rabbits; Ultraviolet Rays; Voriconazole | 2018 |
Lack of correlation of ECV and outcome in an in vivo murine model of systemic fusariosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Fusariosis; Fusarium; Mice; Voriconazole | 2018 |
[Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fusariosis; Humans; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2018 |
An Unusual Etiology for Osteomyelitis in an Immunocompetent Host.
Topics: Antifungal Agents; Fracture Fixation, Internal; Fusariosis; Fusarium; Humans; Immunocompetence; Internal Fixators; Male; Middle Aged; Osteomyelitis; Voriconazole | 2019 |
Management of Fusarium keratitis and its associated fungal iris nodule with intracameral voriconazole and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fusariosis; Humans; Iris Diseases; Keratitis; Male; Middle Aged; Mycetoma; Voriconazole | 2014 |
Disseminated fusariosis with immune reconstitution syndrome and cracking mycotic aortic aneurysm in a 55-year-old patient with acute myeloid leukaemia.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Female; Fusariosis; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2013 |
Improvement in the outcome of invasive fusariosis in the last decade.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Female; Fusariosis; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2014 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Successful treatment of Fusarium keratitis after photo refractive keratectomy.
Topics: Adult; Antifungal Agents; Cornea; Diagnosis, Differential; Eye Infections, Fungal; Female; Follow-Up Studies; Fusariosis; Fusarium; Humans; Keratitis; Myopia; Ophthalmic Solutions; Photorefractive Keratectomy; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 2013 |
Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cataract Extraction; Disease Outbreaks; Endophthalmitis; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2014 |
Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis.
Topics: Animals; Antifungal Agents; Combined Modality Therapy; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Rabbits; Treatment Outcome; Ultraviolet Therapy; Voriconazole | 2014 |
Airway complication contributing to disseminated fusariosis after lung transplantation.
Topics: Aged; Anidulafungin; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Female; Fusariosis; Fusarium; Humans; Lung Diseases, Fungal; Lung Transplantation; Voriconazole | 2014 |
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Canada; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Prospective Studies; Registries; Survival Analysis; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult | 2014 |
In vitro combination of voriconazole and miltefosine against clinically relevant molds.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fusariosis; Fusarium; Microbial Sensitivity Tests; Phosphorylcholine; Scedosporium; Voriconazole | 2014 |
Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency.
Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Hip; Catheter-Related Infections; Central Venous Catheters; Female; France; Fusariosis; Fusarium; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Voriconazole | 2015 |
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
Topics: Adult; Amphotericin B; Amputation, Surgical; Antifungal Agents; Aspergillosis; Blast Injuries; Burns; Critical Illness; Debridement; Drug Monitoring; Fusariosis; Humans; Male; Mucormycosis; Mycoses; Voriconazole; War-Related Injuries; Wounds, Penetrating | 2015 |
Atypical Clinical Presentation of a Newer Generation Anti-Fungal Drug-Resistant Fusarium Infection After a Modified Multi-Visceral Transplant.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Esophagus; Fatal Outcome; Female; Fusariosis; Humans; Immunocompromised Host; Middle Aged; Organ Transplantation; Palate, Hard; Treatment Failure; Voriconazole | 2015 |
In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
Topics: Antifungal Agents; Dermatomycoses; Drug Combinations; Drug Interactions; Drug Synergism; Echinocandins; Fusariosis; Fusarium; Itraconazole; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole | 2016 |
Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fusariosis; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Treatment Outcome; Voriconazole; Young Adult | 2016 |
In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
Topics: Adult; Aged, 80 and over; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Voriconazole; Young Adult | 2016 |
Fusarium dimerum Species Complex (Fusarium penzigii) Keratitis After Corneal Trauma.
Topics: Aged, 80 and over; Antifungal Agents; Corneal Injuries; Female; Fusariosis; Fusarium; Humans; Keratitis; Ophthalmic Solutions; Treatment Outcome; Voriconazole | 2016 |
[Topical voriconazole as an effective treatment for fungal keratitis].
Topics: Administration, Topical; Adult; Alternariosis; Antifungal Agents; Aspergillosis; China; Eye Infections, Fungal; Female; Fusariosis; Humans; Keratitis; Male; Treatment Outcome; Voriconazole | 2016 |
Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antifungal Agents; Female; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intertrigo; Leukemia; Male; Middle Aged; Onychomycosis; Prospective Studies; Skin; Triazoles; Voriconazole; Young Adult | 2016 |
Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.
Topics: Administration, Ophthalmic; Adult; Aged; Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Female; Fusariosis; Humans; Injections, Intralesional; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Fusariosis; Fusarium; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fusariosis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Voriconazole | 2012 |
Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
Topics: Adolescent; Antifungal Agents; Fluorides; Fusariosis; Humans; Leukemia, Myeloid, Acute; Male; Periostitis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole.
Topics: Adult; Antifungal Agents; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Liver Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient.
Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Skin; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Corneal Ulcer; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Fungal; Epithelium, Corneal; Eye Infections, Fungal; Fusariosis; Fusarium; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microscopy, Confocal; Natamycin; Pyrimidines; Triazoles; Virulence; Voriconazole | 2012 |
Intra-articular injection of voriconazole for Fusarium solani arthritis after bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Arthritis; Bone Marrow Transplantation; Fusariosis; Fusarium; Histocytochemistry; Humans; Immunocompromised Host; Injections, Intra-Articular; Male; Microscopy; Pyrimidines; Skin; Triazoles; Voriconazole | 2012 |
Benefit of polyhexamethylene biguanide in Fusarium keratitis.
Topics: Adult; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fungi; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2012 |
The efficacy of voriconazole in 24 ocular Fusarium infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2012 |
[Combination antifungal therapy in hematopoietic stem cell transplantation patients].
Topics: Amphotericin B; Antifungal Agents; Child; Dermatomycoses; Drug Therapy, Combination; Fusariosis; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Male; Nasopharyngeal Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
[Favorable outcome in a case of complicated fungal keratitis].
Topics: Abscess; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Diabetes Complications; Eye Injuries; Female; Fusariosis; Fusarium; Humans; Keratitis; Lens Implantation, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Voriconazole; Wound Infection | 2013 |